A detailed history of Cerity Partners LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 79,290 shares of BHC stock, worth $581,988. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,290
Previous 69,312 14.4%
Holding current value
$581,988
Previous $483,000 33.75%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.22 - $8.26 $52,085 - $82,418
9,978 Added 14.4%
79,290 $646,000
Q2 2024

Aug 13, 2024

SELL
$6.1 - $10.41 $133,443 - $227,729
-21,876 Reduced 23.99%
69,312 $483,000
Q1 2024

May 14, 2024

BUY
$7.77 - $10.61 $708,530 - $967,504
91,188 New
91,188 $967,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.66B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.